Icariin alleviates rheumatoid arthritis via regulating miR-223-3p/NLRP3 signalling axis

References

• Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010;233(1):233–255.
   PubMed Web of Science ®Google Scholar
• McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205–2219.
   PubMed Web of Science ®Google Scholar
• Yang XK, Liu J, Chen SY, et al. UBASH3A gene polymorphisms and expression profile in rheumatoid arthritis. Autoimmunity. 2019;52(1):21–26.
   PubMed Web of Science ®Google Scholar
• McInnes IB, Buckley CD, Isaacs JD. Cytokines in rheumatoid arthritis – shaping the immunological landscape. Nat Rev Rheumatol. 2016;12(1):63–68.
   PubMed Web of Science ®Google Scholar
• Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. Lancet. 2017;389(10086):2338–2348.
   PubMed Web of Science ®Google Scholar
• Chen KM, Ge BF, Ma HP, et al. Icariin, a flavonoid from the herb Epimedium enhances the osteogenic differentiation of rat primary bone marrow stromal cells. Pharmazie. 2005;60(12):939–942.
   PubMed Web of Science ®Google Scholar
• Nian H, Ma MH, Nian SS, et al. Antiosteoporotic activity of icariin in ovariectomized rats. Phytomedicine. 2009;16(4):320–326.
   PubMed Web of Science ®Google Scholar
• Wei CC, Ping DQ, You FT, et al. Icariin prevents cartilage and bone degradation in experimental models of arthritis. Mediators Inflamm. 2016;2016:9529630.
   PubMed Web of Science ®Google Scholar
• Sun P, Liu Y, Deng X, et al. An inhibitor of cathepsin K, icariin suppresses cartilage and bone degradation in mice of collagen-induced arthritis. Phytomedicine. 2013;20(11):975–979.
   PubMed Web of Science ®Google Scholar
• Chi L, Gao W, Shu X, et al. A natural flavonoid glucoside, icariin, regulates Th17 and alleviates rheumatoid arthritis in a murine model. Mediators Inflamm. 2014;2014:1–10.
   Web of Science ®Google Scholar
• Mathews RJ, Robinson JI, Battellino M, et al.; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS). Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Ann Rheum Dis. 2014;73(6):1202–1210.
   PubMed Web of Science ®Google Scholar
• Choulaki C, Papadaki G, Repa A, et al. Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis. Arthritis Res Ther. 2015;17(1):257.
   PubMedGoogle Scholar
• Guo C, Fu R, Wang S, et al. NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis. Clin Exp Immunol. 2018;194(2):231–243.
   PubMed Web of Science ®Google Scholar
• Su B, Ye H, You X, et al. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome . Life Sci. 2018;208:26–32.
   PubMed Web of Science ®Google Scholar
• Zu Y, Mu Y, Li Q, et al. Icariin alleviates osteoarthritis by inhibiting NLRP3-mediated pyroptosis. J Orthop Surg Res. 2019;14(1):307.
   PubMed Web of Science ®Google Scholar
• Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol. 2007;23:175–205.
   PubMed Web of Science ®Google Scholar
• Stanczyk J, Pedrioli DML, Brentano F, et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 2008;58(4):1001–1009.
   PubMed Web of Science ®Google Scholar
• Stanczyk J, Ospelt C, Karouzakis E, et al. Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheum. 2011;63(2):373–381.
   PubMedGoogle Scholar
• Murata K, Yoshitomi H, Tanida S, et al. Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis. Arthritis Res Ther. 2010;12(3):R86.
   PubMed Web of Science ®Google Scholar
• Churov AV, Oleinik EK, Knip M. MicroRNAs in rheumatoid arthritis: altered expression and diagnostic potential. Autoimmun Rev. 2015;14(11):1029–1037.
   PubMed Web of Science ®Google Scholar
• Castro-Villegas C, Pérez-Sánchez C, Escudero A, et al. Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα. Arthritis Res Ther. 2015;17:49.
   PubMed Web of Science ®Google Scholar
• Ogando J, Tardáguila M, Díaz-Alderete A, et al. Notch-regulated miR-223 targets the aryl hydrocarbon receptor pathway and increases cytokine production in macrophages from rheumatoid arthritis patients. Sci Rep. 2016;6:20223.
   PubMed Web of Science ®Google Scholar
• Dunaeva M, Blom J, Thurlings R, et al. Circulating serum miRmiR. Clin Exp Immunol. 2018; 193: 376–385.
   Google Scholar
• Filková M, Aradi B, Šenolt L, et al. Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis. Ann Rheum Dis. 2014;73(10):1898–1904.
   PubMed Web of Science ®Google Scholar
• Shibuya H, Nakasa T, Adachi N, et al. Overexpression of microRNA-223 in rheumatoid arthritis synovium controls osteoclast differentiation. Mod Rheumatol. 2013;23(4):674–685.
   PubMed Web of Science ®Google Scholar
• Liu Y, Yan X. Eriodictyol inhibits survival and inflammatory responses and promotes apoptosis in rheumatoid arthritis fibroblast astrthritis synovium controls osteoclast difference. J Cell Biochem. 2019;120(9):14628–14635.
   PubMed Web of Science ®Google Scholar
• Mor A, Abramson SB, Pillinger MH. The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clin Immunol. 2005;115(2):118–128.
   PubMed Web of Science ®Google Scholar
• Li C, Li Q, Mei Q, et al. Pharmacological effects and pharmacokinetic properties of icariin, the major bioactive component in Herba epimedii. Life Sci. 2015;126:57–68.
   PubMed Web of Science ®Google Scholar
• Liu MH, Sun JS, Tsai SW, et al. Icariin protects murine chondrocytes from lipopolysaccharide-induced inflammatory responses and extracellular matrix degradation. Nutr Res. 2010;30(1):57–65.
   PubMed Web of Science ®Google Scholar
• Hsieh TP, Sheu SY, Sun JS, et al. Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis . Phytomedicine. 2011;18(2–3):176–185.
   PubMed Web of Science ®Google Scholar
• Zhai YK, Guo XY, Ge BF, et al. Icariin stimulates the osteogenic differentiation of rat bone marrow stromal cells via activating the PI3K-AKT-eNOS-NO-cGMP-PKG. Bone. 2014;66:189–198.
   PubMed Web of Science ®Google Scholar
• Pan L, Zhang Y, Chen N, et al. Icariin regulates cellular functions and gene expression of osteoarthritis patient-derived human fibroblast-like synoviocytes. Int J Mol Sci. 2017;18: 2656.
   PubMed Web of Science ®Google Scholar
• Li Y. Effect of icariin on osteoarthritis fibroblast-like synoviocytes: an in vitro study. Mol Cell Biomech. 2019;16:118.
   Google Scholar
• McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007;7(6):429–442.
   PubMed Web of Science ®Google Scholar
• Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014;15(8):509–524.
   PubMed Web of Science ®Google Scholar
• Zeng L, Cui J, Wu H, et al. The emerging role of circulating microRNAs as biomarkers in autoimmune diseases. Autoimmunity. 2014;47(7):419–429.
   PubMed Web of Science ®Google Scholar
• Fulci V, Scappucci G, Sebastiani GD, et al. miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis. Hum Immunol. 2010;71(2):206–211.
   PubMed Web of Science ®Google Scholar
• Lu MC, Yu CL, Chen HC, et al. Increased miR-223 is overexpressed in T-insulin‐like growth factor‐1‐mediated interleukin‐10 production. Clin Exp Immunol. 2014;177:641–651.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wu H, Zhao M, et al. Identifying the differentially expressed microRNAs in autoimmunity: a systemic review and meta-analysis. Autoimmunity. 2020;53(3):122–136.
   PubMed Web of Science ®Google Scholar
• Miao C, Yu H, Chang J, et al. miR-148b-3p affects the pathogenesis of adjuvant-induced arthritis rats through the direct target DNMT1. Autoimmunity. 2018;51(2):43–52.
   PubMed Web of Science ®Google Scholar
• Johnnidis JB, Harris MH, Wheeler RT, et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature. 2008;451(7182):1125–1129.
   PubMed Web of Science ®Google Scholar
• Jia CY, Li HH, Zhu XC, et al. MiR-223 suppresses cell proliferation by targeting IGF-1R. PLoS One. 2011;6(11):e27008.
   PubMed Web of Science ®Google Scholar
• Zamani P, Oskuee RK, Atkin SL, et al. MicroRNAs as important regulators of the NLRP3 inflammasome. Prog Biophys Mol Biol. 2020;150:50–61.
   PubMed Web of Science ®Google Scholar
• Haneklaus M, Gerlic M, Kurowska-Stolarska M, et al. Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1β production. J Immunol. 2012;189(8):3795–3799.
   PubMed Web of Science ®Google Scholar